The history of multiple sclerosis: the changing frame of the disease over the centuries, Journal of the Neurological Sciences, vol.277, pp.3-8, 2009. ,
DOI : 10.1016/S0022-510X(09)70003-6
Immunit?? adaptative et physiopathologie de la scl??rose en plaques, La Revue de M??decine Interne, vol.34, issue.8, pp.479-486, 2013. ,
DOI : 10.1016/j.revmed.2013.03.327
Pathogenesis of multiple sclerosis, Current Opinion in Neurology, vol.18, issue.3, pp.225-230, 2005. ,
DOI : 10.1097/01.wco.0000169737.99040.31
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination, Annals of Neurology, vol.143, issue.6, pp.707-717, 2000. ,
DOI : 10.1159/000111858
La Part de L " inflammation Dans La Pathogénie de La Sclérose En Plaques, Pratique Neurologique - FMC, pp.156-59, 2015. ,
The contribution of demyelination to axonal loss in multiple sclerosis, Brain, vol.129, issue.6, pp.1507-1516, 2006. ,
DOI : 10.1093/brain/awl074
The relation between inflammation and neurodegeneration in multiple sclerosis brains, Brain, vol.79, issue.Pt 11, pp.1175-89, 2009. ,
DOI : 10.1016/S0074-7742(07)79020-7
The pathogenesis of multiple sclerosis: is it really a primary inflammatory process?, Multiple Sclerosis Journal, vol.49, issue.3, pp.326-329, 2004. ,
DOI : 10.1093/brain/122.12.2279
How Many People in the World Have Multiple Sclerosis?, Neuroepidemiology, vol.13, issue.1-2, pp.1-7, 1994. ,
DOI : 10.1159/000110351
??pid??miologie de la scl??rose en plaques??: la particularit?? fran??aise, Revue Neurologique, vol.165, issue.8-9, pp.671-75, 2009. ,
DOI : 10.1016/j.neurol.2009.04.003
Increasing incidence of multiple sclerosis among women in Lorraine ,
Environmental factors in multiple sclerosis, Expert Review of Neurotherapeutics, vol.83, issue.5, pp.3-9, 2013. ,
DOI : 10.1136/jnnp-2011-301876
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses, The Lancet Neurology, vol.14, issue.3, pp.263-273, 2015. ,
DOI : 10.1016/S1474-4422(14)70267-4
Pr??venir la scl??rose en plaques??: un objectif r??aliste???, Revue Neurologique, vol.168, issue.11, pp.836-845, 2012. ,
DOI : 10.1016/j.neurol.2012.07.008
Multiple Sclerosis: Light at the end of the tunnel, European Journal of Human Genetics, vol.74, issue.3 ,
DOI : 10.1086/380997
T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study, European Journal of Neurology, vol.50, issue.1, pp.37-42, 2001. ,
DOI : 10.1001/archneur.56.3.345
Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis, European Journal of Neurology, vol.69, issue.Suppl. 2, pp.1091-1099, 2008. ,
DOI : 10.1212/01.wnl.0000276992.17011.b5
Correlating Brain Atrophy With Cognitive Dysfunction, Mood Disturbances, and Personality Disorder in Multiple Sclerosis, Journal of Neuroimaging, vol.14, issue.3, pp.36-45, 2004. ,
DOI : 10.1177/1051228404266267
Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA, Journal of Magnetic Resonance Imaging, vol.26, issue.3, pp.559-565, 2008. ,
DOI : 10.1212/01.WNL.0000120663.85143.B3
Reproducibility and Accuracy of Quantitative Magnetic Resonance Imaging Techniques of Whole-Brain Atrophy Measurement in Multiple Sclerosis, Journal of Neuroimaging, vol.62, issue.1, pp.27-36, 2005. ,
DOI : 10.1212/01.WNL.0000120663.85143.B3
Measuring Brain Atrophy in Multiple Sclerosis, Journal of Neuroimaging, vol.54, pp.10-15, 2007. ,
DOI : 10.1212/WNL.54.4.782
Measurement of Brain and Spinal Cord Atrophy by Magnetic Resonance Imaging as a Tool to Monitor Multiple Sclerosis, Journal of Neuroimaging, vol.121, issue.suppl 1, pp.30-45, 2005. ,
DOI : 10.1111/jon200010267
Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis, Journal of Neuroimaging, vol.67, issue.Pt 1, pp.62-67, 2015. ,
DOI : 10.1212/01.wnl.0000237551.26858.39
Gray matter atrophy in multiple sclerosis: A longitudinal study, Annals of Neurology, vol.62, issue.pt 6, pp.255-265, 2008. ,
DOI : 10.1002/ana.21113
Gray matter atrophy is related to long-term disability in multiple sclerosis, Annals of Neurology, vol.338, issue.pt 11, pp.247-254, 2008. ,
DOI : 10.1056/NEJM199801293380502
Regionally Distinct White Matter Lesions Do Not Contribute to Regional Gray Matter Atrophy in Patients with Multiple Sclerosis, Journal of Neuroimaging, vol.236, issue.Pt 1, pp.210-218, 2011. ,
DOI : 10.1148/radiol.2361040450
Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years, American Journal of Neuroradiology, vol.74, issue.10, pp.1931-1939, 2013. ,
DOI : 10.1111/j.1600-0404.2012.01662.x
Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis, Radiology, vol.268, issue.3, pp.831-841, 2013. ,
DOI : 10.1148/radiol.13122424
Longitudinal gray matter changes in multiple sclerosis-Differential scanner and overall disease-related effects, Human Brain Mapping, vol.13, issue.5, pp.1225-1245, 2012. ,
DOI : 10.1006/nimg.2000.0716
Putaminal alteration in multiple sclerosis patients with spinal cord lesions, Journal of Neural Transmission, vol.112, issue.Pt 1, pp.10-1007, 2015. ,
DOI : 10.1093/brain/112.1.133
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis, American Journal of Neuroradiology, vol.21, issue.3, pp.1573-1578, 2012. ,
DOI : 10.1111/j.1552-6569.2010.00482.x
Functional brain networks: Linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG Study, Human Brain Mapping, vol.29, issue.2, pp.603-618, 2015. ,
DOI : 10.1002/hbm.20465
Gray matter atrophy and disability progression in patients with early relapsing???remitting multiple sclerosis, Journal of the Neurological Sciences, vol.282, issue.1-2, pp.112-119, 2009. ,
DOI : 10.1016/j.jns.2008.12.005
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS, Journal of the Neurological Sciences, vol.282, issue.1-2, pp.106-111, 2009. ,
DOI : 10.1016/j.jns.2008.11.018
Gray matter atrophy is associated with functional connectivity reorganization during the Paced Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS), Journal of Neuroradiology, vol.42, issue.3, pp.141-149, 2015. ,
DOI : 10.1016/j.neurad.2015.02.006
Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability, Neuroscience & Biobehavioral Reviews, vol.37, issue.5, pp.819-830, 2013. ,
DOI : 10.1016/j.neubiorev.2013.03.006
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge, Acta Neurologica Scandinavica, vol.74, issue.Pt 6, pp.32-36, 2014. ,
DOI : 10.1002/ana.23882
Regional Brain Atrophy Is Associated With Physical Disability in Multiple Sclerosis: Semiquantitative Magnetic Resonance Imaging and Relationship to Clinical Findings, Journal of Neuroimaging, vol.57, issue.suppl 2, pp.129-136, 2001. ,
DOI : 10.1212/WNL.54.8.1689
Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes, Multiple Sclerosis and Related Disorders, vol.4, issue.1, pp.47-51, 2015. ,
DOI : 10.1016/j.msard.2014.11.002
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.55, issue.(Pt 11), pp.410-418, 2015. ,
DOI : 10.1007/s00234-013-1204-3
Spinal cord gray matter atrophy correlates with multiple sclerosis disability, Annals of Neurology, vol.269, issue.1, pp.568-580, 2014. ,
DOI : 10.1148/radiol.13122566
MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability, AJNR Am J Neuroradiol, vol.18, pp.1041-1048, 1997. ,
Spinal cord atrophy and disability in multiple sclerosis, Brain, vol.119, issue.3, pp.701-708, 1996. ,
DOI : 10.1093/brain/119.3.701
Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates, Journal of Neurology, vol.248, issue.4, pp.297-303, 2001. ,
DOI : 10.1007/s004150170204
Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.1, pp.51-55, 2006. ,
DOI : 10.1136/jnnp.2005.068338
Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.66, issue.3, pp.323-330, 1999. ,
DOI : 10.1136/jnnp.66.3.323
Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon ??-1a (Rebif) treatment trial, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.8, pp.1090-1094, 2003. ,
DOI : 10.1136/jnnp.74.8.1090
Cervical cord area measurement using volumetric brain magnetic resonance imaging in multiple sclerosis, Multiple Sclerosis and Related Disorders, vol.4, issue.1, pp.52-57, 2015. ,
DOI : 10.1016/j.msard.2014.11.004
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosis, NeuroImage, vol.50, issue.2, pp.446-455, 2010. ,
DOI : 10.1016/j.neuroimage.2009.12.121
Normalized Upper Cervical Spinal Cord Atrophy in Multiple Sclerosis, Journal of Neuroimaging, vol.42, issue.3 Suppl, pp.320-327, 2008. ,
DOI : 10.1212/WNL.51.1.234
Comparison of Three Different Methods for Measurement of Cervical Cord Atrophy in Multiple Sclerosis, American Journal of Neuroradiology, vol.8, issue.6, pp.319-325, 2008. ,
DOI : 10.1191/1352458502ms849xx
Upper cervical spinal cord cross-sectional area in relapsing remitting multiple sclerosis: Application of a new technique for measuring cross-sectional area on magnetic resonance images, Journal of Magnetic Resonance Imaging, vol.24, issue.1, pp.61-65, 2007. ,
DOI : 10.1148/radiology.172.2.2748838
Application of a B-spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three-dimensional MR images, Journal of Magnetic Resonance Imaging, vol.66, issue.3, pp.368-371, 2003. ,
DOI : 10.1136/jnnp.66.3.323
Improved MRI quantification of spinal cord atrophy in multiple sclerosis, Journal of Magnetic Resonance Imaging, vol.18, issue.3, pp.617-623, 2014. ,
DOI : 10.1002/jmri.10354
A longitudinal MRI study of cervical cord atrophy in multiple sclerosis, Journal of Neurology, vol.105, issue.6???7, pp.1622-1628, 2015. ,
DOI : 10.1097/01.bsd.0000181294.67212.79
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration, Multiple Sclerosis Journal, vol.20, issue.1, pp.72-80, 2014. ,
DOI : 10.1007/s00415-010-5563-y
Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.70, issue.4, pp.544-547, 2001. ,
DOI : 10.1136/jnnp.70.4.544
Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing???remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry, Multiple Sclerosis and Related Disorders, vol.4, issue.3, pp.264-272, 2015. ,
DOI : 10.1016/j.msard.2015.04.003
Measurement of Spinal Cord Atrophy in Multiple Sclerosis, Journal of Neuroimaging, vol.14, issue.3, pp.20-26, 2004. ,
DOI : 10.1177/1051228404266265
Treating relapsingremitting multiple sclerosis: therapy effects on brain atrophy, J. Neurol, 2015. ,
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis, Annals of Neurology, vol.70, issue.1, pp.43-49, 2014. ,
DOI : 10.1136/jnnp.70.4.494
Impact of Disease-Modifying Therapies on Brain and Spinal Cord Atrophy in Multiple Sclerosis, Journal of Neuroimaging, vol.14, issue.3, pp.54-64, 2004. ,
DOI : 10.1177/1051228404266269
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS, Neurology, vol.67, issue.6, pp.944-953, 2006. ,
DOI : 10.1212/01.wnl.0000237994.95410.ce
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif??) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis, Multiple Sclerosis Journal, vol.6, issue.131, pp.585-91, 2005. ,
DOI : 10.1097/01376517-199906000-00006
Efficacy and safety of interferon beta-1b sc in older RRMS patients???a posthoc analysis of the BEYOND study, Journal of Neurology, vol.44, issue.7, pp.1838-1883, 2013. ,
DOI : 10.1016/j.otc.2011.01.013
Randomized study combining interferon and glatiramer acetate in multiple sclerosis, Annals of Neurology, vol.53, issue.3, pp.327-367, 2013. ,
DOI : 10.1212/WNL.53.8.1698
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis, European Journal of Neurology, vol.260, issue.Pt 6, pp.664-71, 2015. ,
DOI : 10.1007/s00415-013-6968-1
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials, Annals of Clinical and Translational Neurology, vol.260, issue.Pt 3, pp.103-121, 2015. ,
DOI : 10.1007/s00415-013-6968-1
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide, Multiple Sclerosis Journal, vol.18, issue.10, pp.1310-1910, 1177. ,
DOI : 10.1136/jnnp.2011.242115
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, ???non-randomized pilot study, European Journal of Neurology, vol.67, issue.6, pp.986-990, 2013. ,
DOI : 10.1159/000334722
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis, Journal of the Neurological Sciences, vol.292, issue.1-2, pp.28-35, 2010. ,
DOI : 10.1016/j.jns.2010.02.012
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS, Neurology, vol.68, issue.17, pp.1390-1401, 2007. ,
DOI : 10.1212/01.wnl.0000260064.77700.fd
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis, New England Journal of Medicine, vol.362, issue.5, pp.402-1510, 2010. ,
DOI : 10.1056/NEJMoa0907839
URL : https://hal.archives-ouvertes.fr/hal-00617750
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study, The Lancet Neurology, vol.10, issue.6, pp.520-549, 2011. ,
DOI : 10.1016/S1474-4422(11)70099-0
Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis, The New England Journal of Medicine, vol.359, issue.17, pp.1786-180110, 1056. ,
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?, Multiple Sclerosis and Related Disorders, vol.4, issue.4, pp.329-333, 2015. ,
DOI : 10.1016/j.msard.2015.04.006
Disease Activity Free Status, JAMA Neurology, vol.71, issue.3, pp.269-70, 2014. ,
DOI : 10.1001/jamaneurol.2013.5486
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study, The Lancet Neurology, vol.8, issue.3, pp.254-60, 2009. ,
DOI : 10.1016/S1474-4422(09)70021-3
New Multiple Sclerosis Phenotypic Classification, European Neurology, vol.72, issue.s1, pp.1-5, 2014. ,
DOI : 10.1159/000367614
URL : http://www.karger.com/Article/Pdf/367614
Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis, BMC Neurology, vol.12, issue.7, p.58, 2014. ,
DOI : 10.1177/1352458506070931
Why some of us do not like the expression ???no evidence of disease activity??? (NEDA) in multiple sclerosis, Multiple Sclerosis and Related Disorders, vol.4, issue.4, pp.383-84, 2015. ,
DOI : 10.1016/j.msard.2015.06.009
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis, Swiss Med Wkly, vol.143, p.13887, 2013. ,
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis, CNS Drugs, vol.8, issue.Pt 11, pp.147-156, 2014. ,
DOI : 10.1038/nrneurol.2011.190
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis, Neurology, vol.84, issue.8, pp.784-793, 2015. ,
DOI : 10.1212/WNL.0000000000001281
Magnetic resonance imaging measures of brain atrophy in multiple sclerosis, Journal of Magnetic Resonance Imaging, vol.2, issue.2, pp.605-618, 2006. ,
DOI : 10.1212/01.WNL.0000149516.30155.B8
Cervical cord and brain grey matter atrophy independently associate with long-term MS disability, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.4, pp.471-472, 2011. ,
DOI : 10.1136/jnnp.2010.205021
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, pp.10-1136, 2015. ,
DOI : 10.1136/jnnp-2014-309903
Eight-year follow-up study of brain atrophy in patients with MS, Neurology, vol.59, issue.9, pp.1412-1420, 2002. ,
DOI : 10.1212/01.WNL.0000036271.49066.06
Clinical impact of early brain atrophy in clinically isolated syndromes, Multiple Sclerosis Journal, vol.51, issue.14, pp.1878-1886, 2013. ,
DOI : 10.1007/s00415-012-6762-5
Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.9, pp.1036-1039, 2006. ,
DOI : 10.1136/jnnp.2006.094748
Spinal cord magnetic resonance imaging in multiple sclerosis: importance of determining degree of atrophy as a marker of disease course], Rev. Neurol. (Paris), vol.156, pp.491-496, 2000. ,
Spinal cord MRI using multi-array coils and fast spin echo: II. Findings in multiple sclerosis, Neurology, vol.43, issue.12, pp.2632-2637, 1993. ,
DOI : 10.1212/WNL.43.12.2632
A multicenter assessment of cervical cord atrophy among MS clinical phenotypes, Neurology, vol.76, issue.24, pp.2096-2102, 2011. ,
DOI : 10.1212/WNL.0b013e31821f46b8
Atrophy and structural variability of the upper cervical cord in early multiple sclerosis, Multiple Sclerosis Journal, vol.20, issue.7, pp.875-884, 2015. ,
DOI : 10.1177/1352458512440516
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort, JAMA Neurology, vol.72, issue.2 ,
DOI : 10.1001/jamaneurol.2014.3537
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients, Multiple Sclerosis Journal, vol.78, issue.3, pp.356-364, 2014. ,
DOI : 10.1177/1352458508098373
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis, Brain and Behavior, vol.2, issue.6, pp.715-728, 2013. ,
DOI : 10.1089/brain.2012.0073
Functional Magnetic Resonance Imaging Correlates of Fatigue in Multiple Sclerosis, NeuroImage, vol.15, issue.3, pp.559-567, 2002. ,
DOI : 10.1006/nimg.2001.1011
Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging, PLoS ONE, vol.67, issue.11, p.78811, 2013. ,
DOI : 10.1371/journal.pone.0078811.t002
On the relation between self-reported cognitive fatigue and the posterior hypothalamic???brainstem network, European Journal of Neurology, vol.8, issue.Pt 5, 2015. ,
DOI : 10.1371/journal.pone.0074156
Structural correlates for fatigue in early relapsing remitting multiple sclerosis, European Radiology, vol.13, issue.2, 2015. ,
DOI : 10.1186/1471-2377-13-73
Fatigue and progression of corpus callosum atrophy in multiple sclerosis, Journal of Neurology, vol.257, issue.12, pp.2199-2205, 2011. ,
DOI : 10.1007/s00415-010-5503-x
MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment, Multiple Sclerosis Journal, vol.6, issue.5, pp.355-361, 2000. ,
DOI : 10.1002/ana.410420318
Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS), Neurology, vol.42, issue.4, pp.859-863, 1992. ,
DOI : 10.1212/WNL.42.4.859
Improved detectability in low signal-to-noise ratio magnetic resonance images by means of a phase-corrected real reconstruction, Medical Physics, vol.16, issue.5, pp.813-817, 1989. ,
DOI : 10.1118/1.596304
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes, Brain, vol.127, issue.5, pp.1101-1107, 2004. ,
DOI : 10.1093/brain/awh126
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis, Journal of Neuroimaging, vol.36, issue.1, pp.63-67, 2014. ,
DOI : 10.1016/j.neuroimage.2007.04.017
Gray matter damage in multiple sclerosis: Impact on clinical symptoms, Neuroscience, vol.303 ,
DOI : 10.1016/j.neuroscience.2015.07.006
Artifacts in 3-T MRI: Physical background and reduction strategies, European Journal of Radiology, vol.65, issue.1, pp.29-35, 2008. ,
DOI : 10.1016/j.ejrad.2007.11.005
Quantification of spinal cord atrophy from magnetic resonance images via a B-spline active surface model, Magnetic Resonance in Medicine, vol.55, issue.6, pp.1176-1185, 2002. ,
DOI : 10.1016/S0262-8856(98)00127-9